You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDX-110

Showing 1 - 25 of 588
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

Brain Cancer, Brain Stem Tumors, Pontine Tumors Trial in Stanford (Rindopepimut)

Terminated
  • Brain Cancer
  • +2 more
  • Rindopepimut
  • Stanford, California
    Stanford University School of Medicine
Sep 20, 2021

Breast Cancer Trial in Seoul (FoundationOne CDx)

Unknown status
  • Breast Cancer
  • FoundationOne CDx
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 19, 2019

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

Completed
  • Glioblastoma
  • +6 more
  • Birmingham, Alabama
  • +44 more
Feb 12, 2020

Exocrine Pancreatic Insufficiency Trial in Adelaide, Auckland, Christchurch (Part A, Part B, Part C)

Recruiting
  • Exocrine Pancreatic Insufficiency
  • Part A
  • +2 more
  • Adelaide, New South Wales, Australia
  • +3 more
Jan 12, 2023

Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

Recruiting
  • Melanoma
  • Metastatic Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 12, 2023

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Chronic Spontaneous Urticaria Trial in Germany, United States (CDX-0159, Normal Saline)

Completed
  • Chronic Spontaneous Urticaria
  • Birmingham, Alabama
  • +13 more
Jan 24, 2023

Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)

Active, not recruiting
  • Cold Urticaria
  • +4 more
  • Berlin, Germany
    Charite University
Dec 20, 2022

Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)

Recruiting
  • Prurigo Nodularis
  • CDX-0159
  • Normal saline
  • Tempe, Arizona
  • +18 more
Jan 4, 2023

Glioma Trial (Blood sampling)

Not yet recruiting
  • Glioma
  • Blood sampling
  • (no location specified)
Oct 31, 2023

Chronic Spontaneous Urticaria Trial in Hungary, United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +44 more
Dec 8, 2022

Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Inducible Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +31 more
Jan 20, 2023

Bunion Trial in Bellaire (Ropivacaine)

Recruiting
  • Bunion
  • Bellaire, Texas
    First Surgical Hospital 4801 Bissonnet Street
Mar 6, 2023

Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • PLD Chemotherapy
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 23, 2022

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic

Not yet recruiting
  • Metastatic Lung Cancer
  • Metastatic Gastrointestinal Cancer
  • FoundationOne® Liquid CDx Assay
  • Standard of Care Diagnostic Pathway
  • (no location specified)
May 11, 2023

Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg

Completed
  • Refractory Chronic Cough
  • 3 mg NOC-100 (via nebulizer)
  • +5 more
  • Phoenix, Arizona
  • +2 more
Nov 16, 2022

Healthy Subjects Trial in Lincoln (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Lincoln, Nebraska
    Celerion, Inc
Jan 20, 2022

Blood Pressure, Perioperative Hypotension Trial in Hamburg (Continuous norepinephrine infusion via an infusion pump, Manual

Not yet recruiting
  • Blood Pressure
  • Perioperative Hypotension
  • Continuous norepinephrine infusion via an infusion pump
  • Manual bolus norepinephrine administration
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Aug 10, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022